1Fung M c,Schultz D J,Solin L J.Ealy-stage Bilateral Breast Cancer Treated with Breast-conserviny Surgery and Definitive Irradiation:The University of Pennsylvania Experience[J].int J Radiat Oncol Biol Phys,2000,38(5):959-964. 被引量：1
2Mauriac L,MacGrogan G,Avril A,et al.Neoadjuvant Chemotherapy for Operable Breast Carcinoma Larger than 3 cm:a Uni-centre Randomized Trial with a 124-month Median Follow-up[J].Annals of Oncolog,1999,10(1) :47-52. 被引量：1
3Schnittrs J.Can We Identify Patients with Invasive Breast Cancer Adequately Treated with Breast-conserving Surgery Alone? [J].Mod Pathol,2002,11 (2):129. 被引量：1
3[2]Fisher B,Anderson S.Conservative surgery for the management of invasive and noninvasive carcinoma of the breast: NSABP trials.World J Surgy,1994,18(1):63-69. 被引量：1
4[3]Veronesi U,Banfi A,Salvadori B,et al.Breast conservation is the treatment of choice in small breast cancer :long-term results of a randomized trial.Eur J Cancer,1990,26:668-670. 被引量：1
5[4]Early Breast Cancer Trailists Collaboration Group.Effects of radiotherapy and surgery in early breast cancer.An overview of the randomized trials.N Engl J Med,1995,333:1444-1455. 被引量：1
6[5]Winchester DJ,Menck HR,Winchester DP.The National Cancer Data Base report on the results of a large non-randomized comparison of breast preservation and modified radical mastectomy.Cancer,1997,80:162-167. 被引量：1
7[6]Rouzier R,Extra JM,Carton M,et al.Primary chemotherapy for operable breast cancer: incidence and prognostic significance of ipsilateral breast tumor recurrence after breast-conserving surgery.J Clin Oncol,2001,19: 3828-3825. 被引量：1
8[7]Fredriksson I,Liljegren G,Arnesson LG,et al.Consequences of axillary recurrence after conservative breast surgery.Br J Surg,2002,89:902-908. 被引量：1
9[8]Fisher B,Dignam J ,Wolmark N,et al.Tamoxifen and chemotherapy for lymph node-negative,estrogen receptor -positive breast cancer.J Natl Cancer Inst,1997,89:1673-1682. 被引量：1
10[9]Julien JP,Bijker N,Fentiman LS,et al.Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomized phase Ⅲ trial 10853.Lancet,2000,355:528-533. 被引量：1
